430,904 Shares in Everus (NYSE:ECG) Bought by US Bancorp DE
US Bancorp DE purchased a new position in shares of Everus (NYSE:ECG - Free Report) in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 430,904 shares of the company's stock, valued at approximately $28,332,000. US Bancorp DE owned approximately 0.85% of Everus at the end of the most recent quarter.
Other institutional investors have also bought and sold shares of the company. Principal Securities Inc. purchased a new position in Everus in the fourth quarter worth $27,000. HighMark Wealth Management LLC purchased a new position in Everus in the fourth quarter worth $28,000. Crews Bank & Trust purchased a new position in Everus in the fourth quarter worth $29,000. Mendota Financial Group LLC purchased a new position in Everus in the fourth quarter worth $36,000. Finally, Blue Trust Inc. purchased a new position in Everus in the fourth quarter worth $38,000.
A number of brokerages have recently commented on ECG. Stifel Nicolaus dropped their price target on Everus from $85.00 to $67.00 and set a "buy" rating on the stock in a research report on Thursday, February 13th. Wolfe Research began coverage on Everus in a research report on Tuesday, December 3rd. They set a "peer perform" rating on the stock. Oppenheimer upped their price target on Everus from $70.00 to $80.00 and gave the company an "outperform" rating in a research report on Tuesday, January 7th. Finally, DA Davidson began coverage on Everus in a research report on Monday, November 4th. They set a "neutral" rating and a $55.00 price target on the stock.
Get Our Latest Stock Report on ECG
Shares of NYSE ECG opened at $41.77 on Monday. The company's fifty day moving average price is $63.22. The company has a debt-to-equity ratio of 0.47, a quick ratio of 1.50 and a current ratio of 1.58. Everus has a one year low of $37.84 and a one year high of $77.93.
Everus (NYSE:ECG - Get Free Report) last issued its quarterly earnings data on Tuesday, February 11th. The company reported $0.67 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.73 by ($0.06). As a group, equities analysts anticipate that Everus will post 2.49 EPS for the current fiscal year.
In related news, Director Rocca Michael Della acquired 1,050 shares of the company's stock in a transaction that occurred on Tuesday, February 18th. The shares were acquired at an average price of $47.56 per share, with a total value of $49,938.00. Following the acquisition, the director now owns 2,027 shares of the company's stock, valued at approximately $96,404.12. This trade represents a 107.47 % increase in their position. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. Also, Director Edward A. Ryan acquired 1,400 shares of the company's stock in a transaction that occurred on Tuesday, February 25th. The shares were bought at an average cost of $38.02 per share, for a total transaction of $53,228.00. Following the acquisition, the director now directly owns 14,928 shares in the company, valued at $567,562.56. This represents a 10.35 % increase in their position. The disclosure for this purchase can be found here. In the last quarter, insiders have purchased 3,750 shares of company stock valued at $153,853.
Everus Construction Group is providing a full spectrum of construction services through its electrical and mechanical and transmission and distribution specialty contracting services principally in United States. Its specialty contracting services are provided to utility, transportation, commercial, industrial, institutional, renewable and other customers.
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to [email protected].
Before you consider Everus, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Everus wasn't on the list.
While Everus currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.